Gut microflora is a key player in host energy homeostasis;Implication de la flore intestinale dans le métabolisme énergétique

Medecine/Sciences

Volumn 24, Issue 5, 2008, Pages 505-510

  Delzenne, Nathalie M ^a   Cani, Patrice D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID;

ADIPOSE TISSUE; DISEASE ASSOCIATION; HOMEOSTASIS; HUMAN; INTESTINE; LIPID DIET; LOW FAT DIET; MICROFLORA; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; REVIEW;

EID: 44949243099     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/2008245505     Document Type: Review

References (31)

1. Tappy L. Metabolic consequences of overfeeding in humans. Curr Opin Clin Nutr Metab Care 2004 ; 7 : 623-8.
2. Levin BE, Keesey RE. Defense of differing body weight set points in diet-induced obese and resistant rats. Am J Physiol 1998 ; 274 : R412-R419.
3. Savage DC. Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol 1977 ; 31 : 107-33.
4. Turnbaugh PJ, Ley RE, Mahowald MA, et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006 ; 444 : 1027-31.
5. Xu J, Mahowald MA, Ley RE, et al. Evolution of Symbiotic Bacteria in the Distal Human Intestine. PLoS Biol 2007 ; 5 : e156.
6. Ley RE, Peterson DA, Gordon JI. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 2006 ; 124 : 837-48.
7. Gill SR, Pop M, Deboy RT, et al. Metagenomic analysis of the human distal gut microbiome. Science 2006 ; 312 : 1355-9.
8. Nicholson JK, Holmes E, Wilson ID. Gut microorganisms, mammalian metabolism and personalized health care. Nat Rev Microbiol 2005 ; 3 : 431-8.
9. Wong JM, De SR, Kendall CW, et al. Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol 2006 ; 40 : 235-43.
10. Hill JO. Understanding and addressing the epidemic of obesity: an energy balance perspective. Endocr Rev 2006 ; 27 : 750-61.
11. Servin AL. Ça «chat» entre la microflore intestinale et l'hôte. Med Sci (Paris) 2007 ; 23 : 229-30.
12. Backhed F, Ding H, Wang T, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 2004 ; 101 : 15718-23.
13. Foufelle F, Hegarty B, Bobard A, et al. Un nouveau rôle de l'insuline dans la régulation du métabolisme glucido-lipidique hépatique. Med Sci (Paris) 2005 ; 21 : 569-71.
14. Ley RE, Turnbaugh PJ, Klein S, et al. Microbial ecology: human gut microbes associated with obesity. Nature 2006 ; 444 : 1022-3.
15. Cani PD, Neyrinck AM, Maton N, et al. Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like Peptide-1. Obes Res 2005 ; 13 : 1000-7.
16. Cani PD, Daubioul CA, Reusens B, et al. Involvement of endogenous glucagon-like peptide-1(7-36) amide on glycaemia-lowering effect of oligofructose in streptozotocin-treated rats. J Endocrinol 2005 ; 185 : 457-65.
17. Cani PD, Knauf C, Iglesias MA, et al. Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor. Diabetes 2006 ; 55 : 1484-90.
18. Cani PD, Joly E, Horsmans Y, et al. Oligofructose promotes satiety in healthy human: a pilot study. Eur J Clin Nutr 2006 ; 60 : 567-72.
19. Keenan MJ, Zhou J, McCutcheon KL, et al. Effects of resistant starch, a non-digestible fermentable fiber, on reducing body fat. Obesity (Silver Spring) 2006 ; 14 : 1523-34.
20. Backhed F, Manchester JK, Semenkovich CF, et al. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci USA 2007 ; 104 : 979-84.
21. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006 ; 444 : 860-7.
22. Neal MD, Leaphart C, Levy R, et al. Enterocyte TLR4 mediates phagocytosis and translocation of bacteria across the intestinal barrier. J Immunol 2006 ; 176 : 3070-9.
23. Vreugdenhil AC, Rousseau CH, Hartung T et al. Lipopolysaccharide (LPS)-binding protein mediates LPS detoxification by chylomicrons. J Immunol 2003 ; 170 : 1399-405.
24. Wright SD, Ramos RA, Tobias PS, et al. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990 ; 249 : 1431-3.
25. Cani PD, Amar J, Iglesias MA, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007 ; 56 : 1761-72.
26. Brun P, Castagliuolo I, Leo VD, et al. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 2007 ; 292 : G518-25.
27. Creely SJ, McTernan PG, Kusminski CM, et al. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab 2007 ; 292 : E740-7.
28. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 1995 ; 125 : 1401-12.
29. Cani PD, Neyrinck AM, Fava F, et al. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 2007 ; 50 : 2374-83.
30. Cani PD, Dewever C, Delzenne NM. Inulin-type fructans modulate gastrointestinal peptides involved in appetite regulation (glucagon-like peptide-1 and ghrelin) in rats. Br J Nutr 2004 ; 92 : 521-6.
31. Delzenne NM, Cani PD, Daubioul C, et al. Impact of inulin and oligofructose on gastrointestinal peptides. Br J Nutr 2005 ; 93 (suppl 1) : S157-61.